Plants (Jul 2022)

Studies Regarding the Pharmaceutical Potential of Derivative Products from <i>Plantain</i>

  • Marilena-Gabriela Olteanu Zaharie,
  • Nicoleta Radu,
  • Lucia Pirvu,
  • Marinela Bostan,
  • Mariana Voicescu,
  • Mihaela Begea,
  • Mariana Constantin,
  • Catalina Voaides,
  • Narcisa Babeanu,
  • Viviana Roman

DOI
https://doi.org/10.3390/plants11141827
Journal volume & issue
Vol. 11, no. 14
p. 1827

Abstract

Read online

In this study, three types of extracts isolated from leaves of Plantain (Plantago lanceolata) were tested for their chemical content and biological activities. The three bioproducts are combinations of polysaccharides and polyphenols (flavonoids and iridoidic compounds), and they were tested for antioxidant, antifungal, antitumor, and prebiotic activity (particularly for polysaccharides fraction). Briefly, the iridoid-enriched fraction has revealed a pro-oxidant activity, while the flavonoid-enriched fraction had a high antioxidant potency; the polysaccharide fraction also indicated a pro-oxidant activity, explained by the co-presence of iridoid glycosides. All three bioproducts demonstrated moderate antifungal effects against Aspergillus sp., Penicillium sp., and dermatophytes, too. Studies in vitro proved inhibitory activity of the three fractions on the leukemic tumor cell line THP-1, the main mechanism being apoptosis stimulation, while the polysaccharide fraction indicated a clear prebiotic activity, in the concentration range between 1 and 1000 µg/mL, evaluated as higher than that of the reference products used, inulin and dextrose, respectively.

Keywords